moxifloxacin has been researched along with Abscess, Pulmonary in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burdette, SD; Polenakovik, H; Polenakovik, S | 1 |
Berçot, B; Fihman, V; Loirat, P; Losser, MR; Mateo, J; Pors, MJ; Raskine, L; Riahi, J | 1 |
Allewelt, M; Lode, H; Lorenz, J; Ott, SR; Reimnitz, P | 1 |
2 trial(s) available for moxifloxacin and Abscess, Pulmonary
Article | Year |
---|---|
Moxifloxacin is efficacious for treatment of community-acquired lung abscesses in adults.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Community-Acquired Infections; Fluoroquinolones; Humans; Lung Abscess; Male; Middle Aged; Moxifloxacin; Quinolines | 2005 |
Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Aza Compounds; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Negative Facultatively Anaerobic Rods; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Lung Abscess; Male; Moxifloxacin; Pneumonia, Aspiration; Quinolines; Radiography; Sulbactam | 2008 |
1 other study(ies) available for moxifloxacin and Abscess, Pulmonary
Article | Year |
---|---|
First successful treatment of Nocardia farcinica brain abscess with moxifloxacin.
Topics: Anti-Infective Agents; Aza Compounds; Biopsy, Needle; Brain Abscess; Fluoroquinolones; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Lung Abscess; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Nocardia; Nocardia Infections; Quinolines; RNA, Ribosomal, 16S; Tomography, X-Ray Computed; Treatment Outcome | 2006 |